Medexus Pharmaceuticals Inc. (OTCMKTS:PDDPF – Get Free Report) shares traded down 33.5% on Monday . The company traded as low as $2.11 and last traded at $2.14. 39,966 shares traded hands during mid-day trading, an increase of 818% from the average session volume of 4,355 shares. The stock had previously closed at $3.22.
Medexus Pharmaceuticals Trading Down 33.5 %
The stock has a 50-day moving average price of $2.14 and a 200 day moving average price of $2.14.
About Medexus Pharmaceuticals
Medexus Pharmaceuticals, Inc operates as a pharmaceutical company. It provide healthcare products to Healthcare Professionals and patients and focuses on therapeutic areas of auto-immune disease and pediatrics. The company products include Rasuvo, Metoject and Rupall. Medexus was founded by Sylvain Chretien in January 2008 and is headquartered in Verdun, Canada.
See Also
- Five stocks we like better than Medexus Pharmaceuticals
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- 3 Value Stocks You Can Buy Before They Become Big
- Investing In Automotive Stocks
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
